Elestrin estradiol gel 0.06%

About
Elestrin

Concentrated on Your Needs

Get Relief of Hot Flashes with a Low Dose of Estrogen

You want hot flash relief. But you may also have concerns about the levels of estrogen in hormone therapy. How do you find both the relief that you deserve and the low dose of estrogen that you want? Elestrin is an FDA-approved estrogen therapy that significantly reduces the frequency and severity of hot flashes associated with menopause1-3 with a low dose of estrogen.2 Elestrin is concentrated on a woman's needs. Find out why so many women are choosing Elestrin as their hot flash and night sweat treatment.

In This Section

  • Advanced absorption technology: Elestrin features a patented Advanced Transdermal Delivery™ (ATD) system1 that allows you to efficiently absorb estrogen2 through the skin and directly into the bloodstream.
  • Significant hot flash relief: Elestrin significantly reduces the frequency and severity of hot flashes associated with menopause.1,2
  • A low dose of estrogen: Learn more interesting facts about Elestrin, including how it delivers estrogen.2
  • The benefits of Elestrin: From effectiveness to convenience to affordability, there are many reasons to choose Elestrin therapy. Please see important safety information including risks, precautions, adverse reactions, and contraindications at the bottom of this page.
  • Discreet gel formulation: Because it's a clear, quick-drying gel, Elestrin is a cosmetically elegant solution for women who prefer a discreet way of getting their estrogen.
  • Elestrin FAQ: Get answers to frequently asked questions about Elestrin therapy.

All estrogen therapy has risks. Please see important safety information at the bottom of this page.

Indication

Elestrin is indicated for the treatment of moderate-to-severe hot flashes and night sweats associated with menopause.

Important Safety Information

Estrogens, with or without progestins, should not be used for the prevention of cardiovascular disease or dementia (decline in memory or thinking skills). Estrogen and progestin therapy has shown an increased risk of breast cancer, heart attack, and blood clots. Estrogen therapy, with or without progestins, increases the risk of stroke and dementia. Estrogen therapy alone increases the risk of cancer of the uterus (womb).

Elestrin should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past; currently have or have had blood clots; currently have or have had liver problems; or think you may be or know that you are pregnant.

The most frequently reported adverse events in clinical trials were nose and throat irritation, breast tenderness, upper respiratory tract infection, and irregular menstrual bleeding.

You and your healthcare provider should discuss whether Elestrin is right for you or whether you still need treatment with Elestrin.

Estrogens, with or without progestins, should be prescribed at the lowest effective doses and for the shortest duration consistent with treatment goals and risks for the individual woman.

Please see full Prescribing Information, including Boxed Warning and Patient Information Sheet.

You are encouraged to report negative side effects of prescription drugs to the FDA (Food and Drug Administration).
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

For more information, call 1-800-890-3098.

References

  1. Elestrin (estradiol gel) full Prescribing Information. Azur Pharma, Philadelphia, PA, July 2010.
  2. Simon JA, Bouchard C, Waldbaum A, et al. Low dose of transdermal estradiol gel for treatment of symptomatic postmenopausal women. Obstet Gynecol. 2007;109:588-96.
  3. Data on file. Jazz Pharmaceuticals